本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Elevation Oncology, Inc.

0.3769
-0.0017-0.45%
盤後0.37960.0027+0.72%18:33 EDT
成交量:42.77萬
成交額:16.10萬
市值:2,233.24萬
市盈率:-0.46
高:0.3800
開:0.3761
低:0.3749
收:0.3786
資料載入中...
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/21

重要事件披露

8-K - Current report
2022/01/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/21

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/10/21

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/06/24

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/24

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/23

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/23

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/21

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/21

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/16

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/11

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/07

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/04

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933